Research has been done into (1) the results of the surgical treatment of the perforated duodenal ulcer in 1983 in 122 patients in 8 university and 12 main training hospitals, and (2) into the possible changes of the surgical policy and the incidence before and after the introduction of cimetidine in the period 1970–1982. Most important changes in policy were the introduction of suture + HSV and a decrease of simple suture and partial gastrectomy. An average of 6 perforated duodenal ulcers per year per clinic was maintained in the period before and after the introduction of cimetidine. Under 40 years of age, male patients suffered far more perforations than female patients; over 70 years, female patients suffered twice as many perforations as male patients. Of the medicines used by patients before perforation (especially older patients), 45% had potentially mucosa-damaging characteristics. Of the patients younger than 60 years, 75% was hospitalized within 12 h; of the patients older than 60 years it was only less than 50%. There was no consensus on the use of antibiotics. Mortality rate was 19% (23 patients, all in the age group 60 years and older). The main cause of death was sepsis. Up until 1983, simple closure and truncal vagotomy + pyloroplasty seemed to be the most frequent surgical treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.